<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.
Find me on:

Recent Posts

Q418/FY18 Market Recap: US Hemostats and Sealants

Posted by Doug Devens on 4/9/19 1:39 PM

The US market for Hemostats and Sealants accelerated in Q418 driven by growth in fibrin sealants and thrombin hemostats, overcoming slow growth during the first half of the year.

The US market for Hemostats and Sealants accelerated with +9.3% YoY growth in Q418, continuing to build on its +7.9% YoY in Q318, with fibrin sealants and thrombin hemostats driving the increase. The US market grew +6.1% in FY18, overcoming slow growth during the first half of the year.

As reported in SmartTRAK Financial Dashboard, every manufacturer in the Hemostats and Sealants market, except Pfizer and CryoLife, experienced revenue growth in Q418. Leading the way was Baxter with +33.1% YoY growth as it made progress with its integration of the Mallinckrodt portfolio. Ethicon and Becton Dickinson (BD) both posted solid gains, with +8.7% YoY and +6.6% YoY growth, respectively...

Read More

Topics: Biosurgery-Hemostats and Sealants, Q418 Market Recaps

Q418/FY18 Market Recap: US Surgical Matrices

Posted by Doug Devens on 4/5/19 9:45 AM

The US Surgical Matrices Market continued to advance in Q418, driven by a resurgence of Becton Dickinson in hernia matrices and continued growth of breast matrices.  The US market grew +9.7% in FY18.

SmartTRAK reports that the US Surgical Matrices market grew in both the Breast and Hernia Repair segments. SmartTRAK estimates the Breast segment grew again at +21.8% YoY growth to 35.2% share of the entire Surgical Matrices market. The Hernia Repair market continued its recovery up +4.8% YoY and 64.8% share of the US Surgical Matrices Market in Q418.  

Among the many topics covered in the Q418/FY18 Surgical Matrices Market Recap are:

Read More

Topics: Advanced Wound Care-Surgical Matrices, Q418 Market Recaps

Growth Amid Debate: Open vs Robotic Techniques for Inguinal Hernia Repair

Posted by Doug Devens on 2/26/19 8:00 AM

Doug Devens, SmartTRAK's Senior Analyst, Biosurgery wrote a fascinating article titled  "Growth Amid Debate: Open vs Robotic Techniques for Inguinal Hernia Repair", in which he shines a light on issues and trends in robotic surgery and the market for inguinal hernia matrices.

Read More

Topics: Hernia, SmartTRAK Conferences

Q318 Market Recap: US Surgical Matrices

Posted by Doug Devens on 1/8/19 9:30 AM

The US Surgical Matrices Market continued to advance in Q318, up +10.3% YoY, fueled by continued rapid adoption of allograft breast matrices and the resurgence of synthetic hernia matrices.

According to BioMedGPS’  SmartTRAK Financial Dashboard, in Q318, the US Surgical Matrices Market grew +10.3% YoY. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted...

Among the many interesting topics covered in the Q318 US Surgical Matrices Market Recap are:

Read More

Topics: Surgical Matrices, Q318 Market Recaps

Q318 US Hemostats and Sealants Market Recap

Posted by Doug Devens on 1/3/19 12:00 PM

The US market for Hemostats and Sealants accelerated substantially in Q318 vs Q218

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market, with the exception of Pfizer, saw revenue growth in Q318. Leading the way were Baxter, with its integration of the Mallinckrodt portfolio, as well as Ethicon and Integra, while Pfizer posted...

Among the many topics covered in the Q318 US Hemostats and Sealants Market Recap are:

Read More

Topics: Biosurgery-Hemostats and Sealants, Q318 Market Recaps

Top Trends in the Hemostats and Sealants Market

Posted by Doug Devens on 11/5/18 9:00 AM

The Hemostats and Sealants Market continues to grow at a steady clip. SmartTRAK projects this market will reach more than $3.5B by 2022E with a five-year CAGR of ~5%.

It’s good news for many, but do you know the real story behind those numbers?

SmartTRAK identifies what’s driving growth in the global Hemostats and Sealants market. In this Market Outlook article, Doug Devens, SmartTRAK's Senior Analyst, Biosurgery, does a deep dive, discussing what’s fueling this growth and reviews the top market trends you need to know for the year ahead.

  • Trend #1: Expanding Indications Fuel Increased Adoption of Fibrin Sealants
  • Trend #2: Increasing Use of Sealant Patch Products
  • Trend #3: New Plant-Based Technologies Gaining Ground
  • Trend #4: Biologic Sealants Ready for Bounce Back

DownloadMarket Outlook: Top Trends to Watch in Hemostats and Sealants

Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Attending Clinical Congress 2018 - American College of Surgeons

Posted by Doug Devens on 10/15/18 10:40 AM

SmartTRAK is excited to be attending ACS - the 2018 Clinical Congress of the American College of Surgeons - on October 21-25 in Boston, Mass. 

Doug Devens, Senior Analyst, Biosurgery and Geoffrey Brown, Director Corporate Accounts, Wound Care will be representing SmartTRAK at the conference. Please  contact us if you would like schedule a meeting at ASC to see what SmartTRAK can do for you.
Read More

Topics: SmartTRAK Conferences

Q218 US Surgical Matrices Market Recap

Posted by Doug Devens on 9/24/18 9:00 AM

The US Surgical Matrices Market advanced again in Q218

In Q218, the US Surgical Matrices Market grew +9.5% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted strong growth in Q218...

Among the many topics covered in the Q218 US Surgical Matrices Recap are:

Read More

Topics: Advanced Wound Care-Surgical Matrices

Q218 US Hemostats and Sealants Market Recap: Revenue Grows

Posted by Doug Devens on 8/29/18 12:04 PM

Baxter, Ethicon and Integra lead the way...

As reported in  SmartTRAK’s Financial Dashboard, the US market for Hemostats and Sealants grew +3.8% YoY in Q218, an increase from +3.1% growth rate overall in Q118. Fibrin sealants continue to lead the way with +7.2% YoY growth in Q218, and thrombin hemostats had a very good quarter with +7.2% growth YoY...

Among the many topics covered in the full Q218 Hemostats and Sealants Market Recap are:

  • Ethicon Continues to Lead Hemostats and Sealants
  • Thrombins Come Back In Hemostats
  • Fibrin Continues To Shine In Sealants
  • Q218 events in the US Hemostats and Sealants Market
Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Publication Alert: Q118 Hemostats and Sealants Market Recap

Posted by Doug Devens on 6/13/18 9:00 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Hemostats and Sealants Market Recap.

Read More

Topics: Biosurgery-Hemostats and Sealants

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts